The pharmacological treatment of alcohol dependence: Needs and possibilities

Alcohol and Alcoholism

Volumn 31, Issue SUPPL. 1, 1996, Pages 55-58

  Mann, Karl ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACAMPROSATE; CARBAMAZEPINE; CLOMETHIAZOLE; DRUG DERIVATIVE; DRUGS USED IN THE TREATMENT OF ADDICTION; TAURINE;

ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOLISM; CLINICAL TRIAL; CONFERENCE PAPER; DIARRHEA; DOSE RESPONSE; GENERAL PRACTITIONER; GERMANY; HEADACHE; HOSPITAL PATIENT; HUMAN; META ANALYSIS; ORAL DRUG ADMINISTRATION; OUTPATIENT; PRIORITY JOURNAL; PSYCHOTHERAPY; SIDE EFFECT; WITHDRAWAL SYNDROME; RECURRENT DISEASE; REVIEW;

ALCOHOL DETERRENTS; ALCOHOLISM; CLINICAL TRIALS; HUMANS; RECURRENCE; TAURINE;

EID: 0029935704     PISSN: 07350414     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.alcalc.a008219     Document Type: Conference Paper

References (24)

1. Aubin, H.-J., Lehert, P., Bauepère, B., Jacquemin, F. and Barrucand, D. (1994) Tolérance de l'association de l'acamprosate aux médicaments du sevrage d'alcool. Alcoologie 16, 32-41.
2. Boismare, F., Daoust, M., Moore, N., Saligaut, C., Lhuintre, J. P., Chretien, P. and Durlach, J. (1984) A homotaurine derivative reduces the voluntary intake of ethanol by rats: are cerebral GABA receptors involved? Pharmacology, Biochemistry and Behaviour 21, 787-789.
3. Chick, J., Gough, K., Falkowski, W., Kershaw, P., Hore, B., Mehta, B., Ritson, B., Ropner, R. and Torley, D. (1992) Disulfiram treatment of alcoholism. British Journal of Psychiatry 161, 84-89.
4. De Witte, P. (1996) The role of neurotransmitters in alcohol dependence: animal research. Alcohol and Alcoholism 31 (Suppl. 1), 13-16.
5. Fuller, R. K., Branchey, L., Brightwell, D. R., Derman, R. M., Emrick, C. D., Iber, F. L., James, K. E., Lacoursiere, R. B., Lee, K. K., Lowenstam, I., Maany, I., Neiderhiser, D., Nocks, J. J. and Shaw, S. (1986) Disulfiram treatment of alcoholism: a Veterans Administration cooperative study. Journal of the American Medical Association 256, 1449-1455.
6. Grant, K. A. and Woolverton, W. L. (1989) Reinforcing and discriminative stimulus effects of Ca-acetyl homotaurine in animals. Pharmacology, Biochemistry and Behaviour 32, 607-611.
7. Küfner, H. and Feuerlein, W. (1989) In-Patient Treatment for Alcoholism: A Multi-Centre Evaluation Study. Springer-Verlag, Berlin.
8. Le Magnen, J., Tran, G., Durlach, J. and Martin, C. (1987) Dose-dependent suppression of the high alcohol intake of chronically intoxicated rats by Ca-acetyl homotaurinate. Alcohol 4, 97-102.
9. Lesch, O. M., Walter, H., Fischer, F., Platz, W., Haring, C., Leitner, A. and Benda, N. (1994) New developments of reducing alcohol intake. Alcoholism: Clinical and Experimental Research 18, 43A.
10. Lhuintre, J.-P., Moore, N. D., Saligaut, C., Boismare, F., Daoust, M., Chretien, P., Tran, G. and Hillemand, B. (1985) Ability of calcium bis acetyl homotaurine, a GABA agonist, to prevent relapse in weaned alcoholics. Lancet i, 1014-1016.
11. Lhuintre, J. P., Moore, N., Tran, G., Steru, L., Langrenon, S., Daoust, M., Parot, P., Ladure, P., Libert, C., Boismare, F. and Hillemand, B. (1990) Acamprosate appears to decrease alcohol intake in weaned alcoholics. Alcohol and Alcoholism 25, 613-622.
12. Littleton, J. M., Dunnage, J. and Pagonis, C. (1988) Alcohol dependence and modulation of neuronal calcium channels. In Biomedical and Social Aspects of Alcohol and Alcoholism, Kuriyama, K., Takada, A. and Ishii, H. eds, pp. 229-234. Elsevier, Amsterdam.
13. Littleton, J. M., Brennan, C. and Bouchenafa, O. (1991) The role of calcium flux in the central nervous system actions of ethanol. Annals of the New York Academy of Sciences 625, 388-394.
14. Mann, K. (1994) Editorial: Alcoholism - still an inferior disease? Addiction 89, 5-7.
15. Mann, K. and Batra, A. (1993) Die gemeindenahe Versorgung von Alkoholäbhangigen. Evaluation eines kombinierten stationären und ambulanten Behandlungskonzeptes. Psychiatrische Praxis 3, 102-105.
16. Paille, F. M., Guelfi, J. D., Perkins, A. C., Royer, R. J., Steru, L. and Parot, P. (1995) Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol. Alcohol and Alcoholism 30, 239-247.
17. Pelc, I., Lebon, O., Verbanck, P., Lehert, P. and Opsomer, L. (1992) Calcium-acetylhomotaurinate for maintaining abstinence in weaned alcoholic patients: a placebo-controlled double-blind multicenter study. In Novel Pharmacological Interventions in Alcoholism, Naranjo, C. A., Sellers, E. eds, pp. 348-352. Springer-Verlag, New York.
18. Pelc, I., Verbanck, P., Lebon, O., Lehert, P., Vacher, C. and Opsomer, L. (1994) Acamprosate in the treatment of alcohol dependence. Presented at the 7th Congress of the International Society for Biomedical Research in Alcoholism (ISBRA), July 1994, Brisbane, Australia.
19. Pettinati, H. M., Sugerman, A. A., DiDonato, N. and Maurer, H. S. (1982) The natural history of alcoholism over four years after treatment. Journal of Studies on Alcohol 43, 201-215.
20. Poldrugo, F., Chabac, S. and Lehert, P. (1994) Acamprosate in the long-term treatment of alcoholism: is its use recommended within the psycho-social approach? Alcoholism: Clinical and Experimental Research 18, 43A.
21. Sass, H., Potgieter, A. S. and Lehert, P. (1995) Results from a pooled analysis of 11 European trials comparing acamprosate and placebo in the treatment of alcohol dependence. Alcohol and Alcoholism 30, 551 (Abstract).
22. Sass, H., Soyka, M., Mann, K. and Zieglgansberger, W. (1996) Relapse prevention by acamprosate: results from a placebo controlled study in alcohol dependence. Archives of General Psychiatry, in press.
23. Wienberg, G. (1992) Die vergessene Mehrheit - Zur Realitat der Versorgung alkohol- und medikamentenabhängiger Menschen. Psychiatrie-Verlag, Bonn.
24. Zeise, M., Madamba, S. G., Siggins, G. R., Putzke, J. and Zieglgänsberger, W. (1994). The anticraving substance acamprosate reduces glutamatergic synaptic transmission and a high-threshold calcium current in neocortical and hippocampal neurons. Alcoholism: Clinical and Experimental Research 18, 36A.